UFP Technologies Q1 sales slightly miss estimates

UFP Technologies

04/05/2026 21:52

Overview

U.S. medical device contract maker's Q1 sales grew 4.1% yr/yr, slightly missed analyst expectations

Adjusted EPS for Q1 beat analyst expectations

Company says slower EPS growth due to labor inefficiencies and new program start-up costs

Outlook

Company expects four large programs to be significant contributors in the second half of 2026

UFP Technologies to increase capacity with two new facilities in the Dominican Republic in Q2

Company cites strong backlog and healthy pipeline of growth opportunities for future periods

Result Drivers

MEDICAL SALES GROWTH - Q1 revenue growth driven by a 5.9% increase in medical sales, with strongest gains in robotic surgery, patient surfaces and support, and interventional and surgical segments

NON-MEDICAL SALES DECLINE - Non-medical sales fell 15% as company shifted focus to MedTech opportunities

LABOR INEFFICIENCIES AND START-UP COSTS - Slower EPS growth partly due to labor inefficiency costs at AJR operation and start-up expenses for four large programs ramping up

Company press release: ID:nBw92m6Qca

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q1 Sales
Slight Miss*
$154.2 mln
$154.78 mln (4 Analysts)
Q1 Adjusted EPS
Beat
$2.48
$2.25 (4 Analysts)
Q1 Net Income
$17.5 mln
Q1 Operating Income
$23.4 mln


*Applies to a deviation of less than 1%; not applicable for per-share numbers.

Analyst Coverage

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy", 2 "hold" and no "sell" or "strong sell"

The average consensus recommendation for the medical equipment, supplies & distribution peer group is "buy"

Wall Street's median 12-month price target for UFP Technologies Inc is $324.50, about 67.2% above its May 1 closing price of $194.07

The stock recently traded at 19 times the next 12-month earnings vs. a P/E of 25 three months ago

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)